SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors digest record financial results, highlighted by a significant year-over-year revenue surge and an accelerated path toward profitability that has energized long-term shareholders. Community discussion is currently dominated by debates over the company's valuation, the impact of historical share dilution, and the potential for a short squeeze as institutional interest grows alongside the expanding backlog of defense and drone infrastructure contracts.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is surging as investors cheer its record revenue, positive EBITDA, and strategic acquisition of Goonhilly Earth Station. The stock is a focal point of intense community debate, with bulls citing multi-year growth potential and upcoming contract catalysts, while others monitor the volatility surrounding its high-volume price swings.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is attracting significant community attention as investors weigh its ongoing growth and strategic partnerships with major tech platforms against a backdrop of high short interest. Market participants are closely watching the upcoming antitrust verdict involving its PriceRunner subsidiary, which many believe could serve as a major catalyst for the stock.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors digest the company's recent Q1 earnings results and updated full-year guidance, while also closely monitoring progress on the commercial rollout of DefenCath and anticipation for clinical data on Rezzayo. Community discussion is focused on the impact of management's profitability turnaround, the effectiveness of ongoing share buyback efforts, and the potential for long-term growth as the company navigates reimbursement dynamics.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors rally ahead of a high-profile plenary session at the AUA Annual Meeting, where the company will present extended clinical data for its lead prostate cancer asset. The community is actively discussing the potential for a significant rerating or buyout, while heightened short interest and strong volume drive speculation regarding a possible short squeeze.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is seeing intense volatility and aggressive call volume as investors react to the sudden departure of the co-founder CEO and a broader executive shakeup. While some members of the community view the leadership transition as a necessary step to secure pending tenant agreements, others are raising concerns about the company's lack of revenue and potential for further downside.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is surging as the market re-rates the company as a critical AI infrastructure play following better-than-expected earnings and a massive boost in hyperscaler AI orders. Investors are focused on its strategic shift toward networking, silicon, and data center connectivity, with many noting its newfound momentum as it breaks toward record highs.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors anticipate a major shift toward an AI and cloud infrastructure powerhouse through its acquisition of Northern Data, fueling intense speculation about a potential short squeeze. Community sentiment remains highly charged, with bulls focused on Tether's strategic backing and insider alignment while aggressively countering bearish narratives regarding earnings and valuation.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently rallying as investors digest the launch of daily dividends on its SATA preferred stock alongside a robust increase in Bitcoin treasury holdings. The community is actively discussing the company's debt-free status and the potential for these daily yields to drive institutional interest, fueling bullish speculation about the stock's future performance.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors rally around the company's aggressive expansion into agentic AI for broadband networks and its integration into the AI-native 6G and cloud infrastructure ecosystem. The community is heavily focused on intense call option activity and potential upcoming milestones, viewing the stock as an undervalued play transitioning into a critical component of the AI supply chain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citizens⬇️ $AVTX&#39;s PT to $55 and reiterated at a Market Outperform rating. 
$ABBV MLTX SLRN UCBJY INCY $NVS 
Citizens said in its note: 
Positive Phase 2 LOTUS results support advancement to registrational studies; we reiterate our Market Outperform rating on Avalo Therapeutics though lower our risk-adjusted, DCF-derived price target to $55 from $62 to reflect the recent equity financing. 
 
This morning, Avalo reported 1Q26 financial results and business updates, underscoring its plans to advance abdakibart into registrational Phase 3 studies. Recall, the Phase 2 LOTUS trial demonstrated positive results (our note here) with, in our view, a robust and competitive magnitude of benefit. The company ended 1Q26 with $82MM in cash, and raised net proceeds of ~$40MM from the equity offering that followed the announcement of Phase 2 results.

Citizens⬆️ $AVTX&#39;s PT to $62 (was $52),⬆️PoA to 70%, reiterated at Market Outperform, and said: Positive Phase 2 results for abdakibart in HS provide clear support for blockbuster potential. 
$NVS $INCY ABBV MLTX UCBJY 
Citizens added—On Tuesday, Avalo announced positive results from the Phase 2 trial evaluating abdakibart in patients with moderate-to-severe hidradenitis suppurativa. 
 
We view the magnitude of benefit (~17% placebo-adjusted HiSCR75 responder rate) as robust and competitive. 
 
Furthermore, the HiSCR75 endpoint met the threshold of success (15%-25%) noted by KOL Dr. David Rosmarin on our recent preview call (see our note here). 
 
The company stated that the safety and tolerability profile of abdakibart was favorable and, most importantly in our view, there were no adverse events related to neutropenia, serious infections, or opportunistic infections. 
 
We have increased our probability of approval for abdakibart in HS from 55% to 70%, driving our increased price target.

StockTwits Web

Avalo Therapeutics Inc

Novartis AG

Incyte Corp.

Quantumup

Abbvie Inc

's PT to $55 and reiterated at a Market Outperform rating. 


 
Citizens said in its note: 
Positive Phase 2 LOTUS results support advancement to registrational studies; we reiterate our Market Outperform rating on Avalo Therapeutics though lower our risk-adjusted, DCF-derived price target to $55 from $62 to reflect the recent equity financing. 
 
This morning, Avalo reported 1Q26 financial results and business updates, underscoring its plans to advance abdakibart into registrational Phase 3 studies. Recall, the Phase 2 LOTUS trial demonstrated positive results (our note here) with, in our view, a robust and competitive magnitude of benefit. The company ended 1Q26 with $82MM in cash, and raised net proceeds of ~$40MM from the equity offering that followed the announcement of Phase 2 results.